"
Impact of Drug-Drug Interaction between CDK4/6 Inhibitors and Proton Pump Inhibitors on Survival Outcomes in the Treatment of Metastatic Breast Cancer—Real World Data from a Portuguese Center"
written by Joana Reis, Inês Costa, Mariana Costa, Ana Valente, Catarina Almeida, Marta Freitas, Cláudia Caeiro, Catarina Fernandes, Nuno Tavares, Miguel Barbosa,
published by
Journal of Cancer Therapy,
Vol.13 No.5, 2022
has been cited by the following article(s):
|
[1]
|
Mitigating the Risk of Drug Interactions in Cancer Patients Taking Oral Anticancer Agents: The Role of a Multidisciplinary Team-Based Medication Reconciliation
Cureus,
2023
DOI:10.7759/cureus.35324
|
|
|
|
|
[2]
|
Concomitant Use of Proton Pump Inhibitors and Palbociclib Among Patients With Breast Cancer
JAMA Network Open,
2023
DOI:10.1001/jamanetworkopen.2023.24852
|
|
|
|